HAP Trading, LLC - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 195 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
HAP Trading, LLC ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$8
-100.0%
67,300
-27.3%
0.00%
-95.2%
Q3 2022$314,000
-1.9%
92,634
+9.8%
0.02%
+31.2%
Q2 2022$320,000
-53.4%
84,357
-34.9%
0.02%
-42.9%
Q1 2022$686,000
-74.3%
129,536
-61.4%
0.03%
-61.6%
Q4 2021$2,671,000
+15.6%
335,776
+33.0%
0.07%
-2.7%
Q3 2021$2,311,000
+311.2%
252,553
+107.5%
0.08%
+341.2%
Q2 2021$562,000
+152.0%
121,707
+13.1%
0.02%
+54.5%
Q1 2021$223,000
-50.6%
107,600
-58.6%
0.01%
-15.4%
Q4 2020$451,000
+3369.2%
259,600
+1004.7%
0.01%
+1200.0%
Q3 2020$13,000
-76.8%
23,500
-68.3%
0.00%
-66.7%
Q2 2020$56,000
+522.2%
74,100
+60.4%
0.00%
+200.0%
Q1 2020$9,000
-25.0%
46,200
+69.9%
0.00%0.0%
Q4 2019$12,00027,200
+35.3%
0.00%
Q2 2019$0
-100.0%
20,100
-60.9%
0.00%
-100.0%
Q4 2016$326,00051,4680.02%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
RP Management, LLC 3,846,154$27,230,77026.28%
Prosight Management, LP 2,408,135$17,049,5965.40%
Kynam Capital Management, LP 3,133,193$22,183,0063.63%
Saturn V Capital Management LP 982,458$6,955,8032.91%
AlphaCentric Advisors LLC 649,000$4,594,9202.61%
TANG CAPITAL MANAGEMENT LLC 1,800,000$12,744,0001.80%
SILVERARC CAPITAL MANAGEMENT, LLC 791,671$5,605,0311.70%
Eversept Partners, LP 2,479,103$17,552,0491.48%
DAFNA Capital Management LLC 652,000$4,616,1601.44%
Avoro Capital Advisors LLC 11,550,000$81,774,0001.28%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders